methyl 1-methyl-4-{[(1-methyl-1H-pyrrol-2-yl)carbonyl]amino}-1H-pyrrole-2-carboxylate | 295805-46-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: methyl 1-methyl-4-{[(1-methyl-1H-pyrrol-2-yl)carbonyl]amino}-1H-pyrrole-2-carboxylate
• 英文别名: methyl 1-methyl-4-(1-methylpyrrole-2-carboxamido)pyrrole-2-carbonate；methyl 1-methyl-4-(1-methyl-1H-pyrrole-2-carboxamido)-1H-pyrrole-2-carboxylate；methyl 1-methyl-4-[(1-methyl-1H-pyrrole-2-carbonyl)-amino]-1H-pyrrole-2-carboxylate；Methyl 1-methyl-4-[(1-methylpyrrole-2-carbonyl)amino]pyrrole-2-carboxylate
• CAS: 295805-46-8
• 化学式: C₁₃H₁₅N₃O₃
• 分子量: 261.28
• InChiKey: HTPARZFXKHGDSS-UHFFFAOYSA-N

物化性质

• 熔点：
  102 °C
• 沸点：
  352.2±32.0 °C(Predicted)
• 密度：
  1.24±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  19
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  65.3
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  methyl 1-methyl-4-{[(1-methyl-1H-pyrrol-2-yl)carbonyl]amino}-1H-pyrrole-2-carboxylate 在 sodium hydroxide 、 1-羟基苯并三唑 、 N,N'-二异丙基碳二亚胺 作用下， 以 甲醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 24.0h， 生成 N-[5-[3-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]propylcarbamoyl]-1-methylpyrrol-3-yl]-1-methyl-4-[(1-methylpyrrole-2-carbonyl)amino]pyrrole-2-carboxamide
  参考文献：
  名称：

  Synthesis of Lipid Derivatives of Pyrrole Polyamide and Their Biological Activity

  摘要：

  合成了新型脂肪酰和磷脂衍生物的吡咯聚酰胺。对其在MT-4细胞癌细胞系及人类免疫缺陷病毒（HIV）感染细胞中的细胞毒性进行了研究。尽管未发现抗HIV活性，但通过在吡咯聚酰胺中引入疏水基团，其对癌细胞的细胞毒性显著增强。

  DOI：

  10.1271/bbb.60650
• 作为产物：
  描述：

  1-甲基-4-硝基吡咯-2-羧酸 在 palladium on activated charcoal 硫酸 、 氢气 、 三乙胺 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 30.0h， 生成 methyl 1-methyl-4-{[(1-methyl-1H-pyrrol-2-yl)carbonyl]amino}-1H-pyrrole-2-carboxylate
  参考文献：
  名称：

  Distamycin Analogues without Leading Amide at Their N-Termini − Comparative Binding Properties to AT- and GC-Rich DNA Sequences

  摘要：

  DOI：

  10.1002/1099-0690(200211)2002:21<3604::aid-ejoc3604>3.0.co;2-x

文献信息

• [EN] SEQUENCE SELECTIVE PYRROLE AND IMIDAZOLE POLYAMIDE METALLOCOMPLEXES<br/>[FR] MÉTALLOCOMPLEXES POLYAMIDES DE PYRROLE ET IMIDAZOLE SELECTIFS VIS-A-VIS DE SEQUENCES
  申请人：UNIV WESTERN SYDNEY

  公开号：WO2005033077A1

  公开（公告）日：2005-04-14

  The present invention relates to sequence selective compounds for targeting therapeutic or diagnostic groups to polynucleotides. More particularly, the present invention relates to sequence selective targeting of metallocomplexes, such as metallodrugs and metallodiagnostics, to polynucleotides.

  本发明涉及用于将治疗或诊断组靶向到多核苷酸的序列选择性化合物。更具体地说，本发明涉及将金属配合物（如金属药物和金属诊断试剂）的序列选择性靶向到多核苷酸。
• Synthesis of pyrrole-imidazole polyamide oligomers based on a copper-catalyzed cross-coupling strategy
  作者：Naoki Shiga、Shihori Takayanagi、Risa Muramoto、Tasuku Murakami、Rui Qin、Yuta Suzuki、Ken-ichi Shinohara、Atsushi Kaneda、Tetsuhiro Nemoto

  DOI：10.1016/j.bmcl.2017.03.052

  日期：2017.5

  properties to the minor groove of DNA. We developed a novel method of synthesizing Py-Im polyamide oligomers based on a Cu-catalyzed cross-coupling strategy. All four patterns of dimer fragments could be synthesized using a Cu-catalyzed Ullmann-type cross-coupling with easily prepared monomer units. Moreover, we demonstrated that pyrrole dimer, trimer, and tetramer building blocks for Py-Im polyamide

  吡咯-咪唑（Py-Im）聚酰胺由于对DNA的微小凹槽具有独特的结合特性，因此是用于化学生物学和药物化学研究的有用工具。我们开发了一种基于Cu催化交叉偶联策略合成Py-Im聚酰胺低聚物的新方法。可以使用具有容易制备的单体单元的Cu催化的Ullmann型交叉偶联来合成所有四个模式的二聚体片段。此外，我们证明了通过结合吡咯/吡咯偶联加成物的位点选择性碘化可得到用于Py-Im聚酰胺合成的吡咯二聚体，三聚体和四聚体结构单元。
• METHOD FOR PRODUCING NITROGEN-CONTAINING AROMATIC AMIDE, METHOD FOR PRODUCING PYRROLE-IMIDAZOLE POLYAMIDE, AND COMPOUND
  申请人：National University Corporation Chiba University

  公开号：US20190084928A1

  公开（公告）日：2019-03-21

  To provide a method for producing a nitrogen-containing aromatic amide that is capable of using a monomer unit obtained under milder reaction condition and uses catalytic amide bond formation, and a method for producing a pyrrole-imidazole polyamide. [1] A method for producing a nitrogen-containing aromatic amide, including reacting a compound 1 represented by the general formula (1) and a compound 2 represented by the general formula (2) in the presence of a transition metal catalyst and a base, so as to provide a compound 3 represented by the general formula (3). [2] A method for producing a pyrrole-imidazole polyamide, including using the compound 3 obtained by the production method according to the item [1]. [3] A compound represented by the general formula (2aa), the general formula (2ab), the general formula (2ac), or the general formula (2ad).

  提供一种生产含氮芳香酰胺的方法，该方法能够使用在较温和的反应条件下获得的单体单元，并利用催化酰胺键形成，以及一种生产吡咯-咪唑聚酰胺的方法。[1] 一种生产含氮芳香酰胺的方法，包括在过渡金属催化剂和碱的存在下，使通式（1）所代表的化合物1与通式（2）所代表的化合物2发生反应，从而提供通式（3）所代表的化合物3。[2] 一种生产吡咯-咪唑聚酰胺的方法，包括使用根据项目[1]的生产方法获得的化合物3。[3] 通式（2aa）、通式（2ab）、通式（2ac）或通式（2ad）所代表的化合物。
• [EN] DNA BINDING AGENTS WITH A MINOR GROOVE BINDING TAIL<br/>[FR] AGENTS LIANT L'ADN AVEC UNE QUEUE SE LIANT AU SILLON MINEUR
  申请人：UNIV TEXAS

  公开号：WO2017049091A1

  公开（公告）日：2017-03-23

  Provided herein are compounds which intercalate into the DNA of a cell and are capable of crossing the blood brain barrier of a formula provided herein. Pharmaceutical compositions of the compounds and methods of treating cancer, for example brain, lung, or pancreatic cancer, are also provided herein.

  本文提供的是一些能够插入细胞DNA并能够穿过血脑屏障的化合物。此外，本文还提供了这些化合物的药物组合物以及治疗癌症的方法，例如大脑、肺部或胰腺癌。
• Alkyl 4- [4- (5-Oxo-2,3,5, 11A-Tetrahydo-5H-Pyrrolo [2, 1-C] [1,4] Benzodiazepine-8-Yloxy) -Butyrylamino]-1H-Pyrrole-2-Carboxylate Derivatives and Related Compounds For the Treatment of a Proliferative Disease
  申请人：Howard Philip Wilson

  公开号：US20080214525A1

  公开（公告）日：2008-09-04

  A compound of formula (I); or a salt or solvate thereof, wherein: the dotted line indicates the optional presence of a double bond between C2 and C3; R 2 is selected from —H, —OH, =0, ═CH 2 , —CN, —R, OR, halo, ═CH—R, O—SO 2 —R, CO 2 R and COR; R 7 is selected from H, R, OH, OR, SH, SR, NH 2 , NHR, NRR′, nitro, Me 3 Sn and halo, where R and R′ are independently selected from optionally substituted C 1-7 alkyl, C 3-20 heterocyclyl and C 5-20 aryl groups; R 10 and R 11 either together form a double bond, or are selected from H and YR Y , where Y is selected from O, S and NH and R is H or C 1-7 alkyl or H and SO x M, where x is 2 or 3 and M is a monovalent pharmaceutically acceptable cation; each X is independently a heteroarylene group; n is from 1 to 6; and R E is C 1-4 alkyl. The compound is useful for the treatment of proliferative diseases.

  化合物的公式（I）；或其盐或溶剂化物，其中：虚线表示C2和C3之间的双键是可选的；R2选择自-H，-OH，=0，═CH2，-CN，-R，OR，卤基，═CH-R，O-SO2-R，CO2R和COR；R7选择自H，R，OH，OR，SH，SR，NH2，NHR，NRR'，硝基，Me3Sn和卤基，其中R和R'独立选择自可选取代的C1-7烷基，C3-20杂环基和C5-20芳基基团；R10和R11要么一起形成双键，要么选择自H和YRY，其中Y选择自O，S和NH，R为H或C1-7烷基或H和SOxM，其中x为2或3，M为一价的药用可接受阳离子；每个X独立地是杂芳基基团；n为1至6；以及RE为C1-4烷基。该化合物可用于治疗增殖性疾病。